Abivax SA (ABVX)
126.14
+0.45
(+0.36%)
USD |
NASDAQ |
Apr 10, 16:00
126.10
-0.04
(-0.03%)
After-Hours: 20:00
Abivax Enterprise Value : 9.401B for April 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 340.24B |
| Eli Lilly & Co. | 875.88B |
| DBV Technologies SA | 959.11M |
| Insmed, Inc. | 32.70B |
| Nicox SA | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -95.40M |
| Total Expenses (Quarterly) | 95.40M |
| EPS Diluted (Quarterly) | -1.215 |
| Earnings Yield | -4.29% |
| Normalized Earnings Yield | -3.755 |